This announcement replaces RNS No 2632M released on 26 April
2024 at 14:13 which misstated the Savills Deferred Share Bonus Plan
grant allocations in respect of R Lee, D Lipson and C Mancini and
consequently the resulting beneficial interests of those
individuals, which should have been stated as
follows:
|
PDMR
|
Number of shares subject to
the Savills Deferred Share Bonus Plan awarded to the PDMR on 24
April 2024
|
Resulting beneficial interest
under the Savills Deferred Share Bonus Plan and Savills Deferred
Share Plan
|
|
Raymond Lee
|
19,704
|
150,278
|
|
David Lipson
|
4,859
|
148,948
|
|
Christian Mancini
|
10,537
|
148,971
|
All
other details remain unchanged. The amended text of the full
announcement of 26 April 2024 is shown below.
SAVILLS PLC (THE "COMPANY")
TRANSACTION IN SHARES BY DIRECTORS AND PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMRS)
Vesting of Share Awards
Awards over ordinary shares of the
Company under the Deferred Share Plan have become unconditional in
all respects following the end of their Deferred Period. In
satisfaction of the Awards, the Trustee of the Savills US Employee
Benefit Trust effected the transfer of shares, following the
settlement of associated tax liabilities through the sale of
shares, to a PDMR of the Company based in North America as
follows:-
|
PDMR
|
Number of Shares
Transferred
|
Number of Shares
Disposed
|
Shareholding following this
notification
|
Shareholding as a % of issued
share capital
|
|
David Lipson
|
39,058
|
19,488
|
103,699
|
0.07%
|
The share price on disposal of shares
was £10.45 per share.
Grant of Share Awards
The Company announces that on 24
April 2024 the grant of the share-based element of 2023 profit
share awards has been made under the Savills Deferred Share Bonus Plan to
Directors and PDMRs as follows:-
|
Director/ PDMR
|
Number of shares subject to
the Savills Deferred Share Bonus Plan awarded to the Director/ PDMR
on 24 April 2024
|
|
Mark Ridley (Director)
|
58,841
|
|
Simon Shaw (Director)
|
45,105
|
|
Alex Jeffrey (PDMR)
|
18,234
|
|
Chris Lee (PDMR)
|
9,596
|
|
Raymond Lee (PDMR)
|
19,704
|
|
David Lipson (PDMR)
|
4,859
|
|
Christian Mancini (PDMR)
|
10,537
|
|
James Sparrow (PDMR)
|
33,589
|
These awards have a Deferred Period
of three years and are subject to rolled-up dividend shares whereby
the number of shares awarded will be increased on the vesting date
to reflect final and interim dividends declared during the Deferred
Period.
The Company announces that on 24
April 2024 the grant of an award has been made under The Schedule
to The Savills Deferred Share Plan to a PDMR based in the United
States of America as follows:-
|
PDMR
|
Number of shares subject to
the Savills Deferred Share Plan awarded to the PDMR on 24 April
2024
|
|
David Lipson (PDMR)
|
38,563
|
One-third of Mr Lipson's award will
vest on each of the three anniversaries subsequent to the date of
grant subject to continued employment and performance. The award is
subject to rolled-up dividend shares whereby the number of shares
awarded will be increased on the vesting dates to reflect final and
interim dividends declared during the Deferred Periods.
Resulting beneficial interests under
the Savills Deferred Share Bonus Plan and Savills Deferred Share
Plan further to the above notifications are as follows:
|
Director/ PDMR
|
Resulting beneficial interest
under the Savills Deferred Share Bonus Plan and Savills Deferred
Share Plan
|
|
Mark Ridley (Director)
|
281,493
|
|
Simon Shaw (Director)
|
214,056
|
|
Alex Jeffrey (PDMR)
|
307,184
|
|
Chris Lee (PDMR)
|
74,917
|
|
Raymond Lee (PDMR)
|
150,278
|
|
David Lipson (PDMR)
|
148,948
|
|
Christian Mancini (PDMR)
|
148,971
|
|
James Sparrow (PDMR)
|
163,057
|
The information set out below is
provided in accordance with the requirements of Article 19 of the
EU Market Abuse Regulation No 596/2014.
|
1.
|
Details of the Director/ PDMR
|
|
(a)
|
Name
|
1. Mark
Ridley
2. Simon
Shaw
3. Alex
Jeffrey
4. Chris
Lee
5. Raymond
Lee
6. David
Lipson
7. Christian
Mancini
8. James
Sparrow
|
|
2.
|
Reason for the notification
|
|
(a)
|
Position/ status
|
1. Group Chief
Executive/ Director
2. Group Chief
Financial Officer/ Director
3. Chief Executive
Officer - Savills Investment Management/ PDMR
4. Group Legal
Director and Company Secretary/ PDMR
5. Chief Executive
- Hong Kong, Macau and Greater China/ PDMR
6. Chief Executive
Officer - Savills North America/ PDMR
7. Chief Executive
Officer - Asia Pacific (ex-Greater China)/ PDMR
8. Chief Executive
Officer, UK & CEME/ PDMR
|
|
(b)
|
Initial notification/
Amendment
|
Initial notification
|
|
3.
|
Details of the issuer
|
|
(a)
|
Name
|
Savills plc
|
|
(b)
|
LEI
|
213800WXICGMBWHTA933
|
|
4.
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
(a)
|
Description of the Financial
Instrument
|
Savills plc Ordinary Shares of 2.5p
each
|
|
(b)
|
Identification code of the Financial
Instrument
|
GB00B135BJ46
|
|
(c)
|
Nature of the transaction
|
1) Vesting of
awards under the Company's Deferred Share Plan and sale of shares
to satisfy associated tax liabilities
2) Grant of awards
over Ordinary Shares in accordance with the Company's Deferred
Share Bonus Plan and Deferred Share Plan
|
|
(d)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
1)
Acquisition
£nil per share
Disposal
£10.45 per share
|
1. n/a
2. n/a
3. n/a
4. n/a
5. n/a
6.
39,058
7. n/a
8. n/a
9. n/a
1. n/a
2. n/a
3. n/a
4. n/a
5. n/a
6.
19,488
7. n/a
8. n/a
9. n/a
|
|
|
|
2)
£nil per share
|
1.
58,541
2.
45,105
3.
18,234
4.
9,596
5.
19,704
6.
43,422
7.
10,537
8.
33,589
|
|
(e)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
(f)
|
Date of the transaction
|
24 April 2024
|
|
(g)
|
Place of the transaction
|
Outside a trading venue
|
Name of contact and telephone number for
queries:
Chris Lee
Group Legal Director & Company
Secretary
020 3107 5444
4 June 2024